Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Probiogen AG manages a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently includes 1 pending office action. This active matter reflects the company's efforts to protect its biotechnological research. The prosecution activity is focused on this outstanding filing.
The prosecution is handled by 1 distinct examiner and 1 distinct art unit. This indicates that the portfolio's active matters are being reviewed in the assigned administrative environment. For practitioners, this means that the prosecution outcome is dependent on the views of the examiner. There is no variation in examination style across the current pending workload.
GOMEZ RODRIGUEZ, JULIO WASHINGTON is the busiest examiner for this portfolio, overseeing 1 busiest examiner pending office action. As this matches the total of 1 pending office action, this examiner is the official currently reviewing the company's active filings. Practitioners should tailor their arguments to the technical expertise of GOMEZ RODRIGUEZ, JULIO WASHINGTON in the Biotechnology & Pharmaceuticals sector.
The alignment of 1 distinct art unit with the Biotechnology & Pharmaceuticals area provides the prosecution landscape. With 1 pending office action, the company can ensure that its legal strategy is executed. This approach reduces the administrative overhead associated with managing a portfolio of biotechnological research.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1 | 41.4% | +58.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17420076 | TRANSPOSASE WITH ENHANCED INSERTION SITE SELECTION PROPERTIES | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 89d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17420076 | TRANSPOSASE WITH ENHANCED INSERTION SITE SELECTION PROPERTIES | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 89d overdue |
| Art Unit | Apps |
|---|---|
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17420076 | TRANSPOSASE WITH ENHANCED INSERTION SITE SELECTION PROPERTIES | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | §102§103§112 | Non-Final OA | 89d overdue | Pending | Jun 30, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial